Cutaneous Lymphomas

On this page

Cutaneous Lymphomas: Overview - Skin's Stealthy Cells

  • Heterogeneous group of extranodal non-Hodgkin lymphomas (NHL) primarily affecting the skin.
  • Clonal proliferations of T-cells, B-cells, or rarely NK-cells.
  • Incidence: ~1 per 100,000; more common in older adults (median age 50-60 years).
  • Cutaneous T-cell lymphomas (CTCLs) are more common (~75%) than cutaneous B-cell lymphomas (CBCLs, ~25%).

⭐ Mycosis fungoides is the most common type of CTCL, often presenting with patches, plaques, and tumors.

Mycosis Fungoides: Patchy Problems - Fungus Mimic Rash

  • Most common Cutaneous T-cell Lymphoma (CTCL); chronic, indolent. Often misdiagnosed as eczema/psoriasis ("fungus mimic").
  • Clinical Progression:
  • Key Histo: Atypical T-lymphocytes (cerebriform/Lutzner cells) forming Pautrier's microabscesses in epidermis.

    ⭐ Pautrier's microabscesses are highly characteristic, not strictly pathognomonic, but a key diagnostic feature.

  • Sézary Syndrome: Advanced, erythrodermic MF variant with >1000/µL circulating Sézary cells (Lutzner cells in blood) & lymphadenopathy.
  • 📌 Mnemonic: My Fungoides = Many Faces (mimics various rashes).

Mycosis Fungoides Histology: Pautrier's Microabscess

Sézary Syndrome: Red Man's Woe - Itchy Crimson Tide

  • Aggressive leukemic variant of Cutaneous T-cell Lymphoma (CTCL).
  • Classic triad:
    • Widespread erythroderma (>80% Body Surface Area).
    • Generalized lymphadenopathy.
    • Circulating atypical T-cells (Sézary cells >1000/μL).
  • Sézary cells: Lymphocytes with characteristic cerebriform nuclei.
  • Other criteria: CD4/CD8 ratio >10; clonal T-cell receptor (TCR) gene rearrangement.
  • Intense pruritus, alopecia, palmoplantar keratoderma common.

⭐ Absolute Sézary cell count >1000/μL in peripheral blood is a major diagnostic criterion for Sézary Syndrome (WHO-EORTC).

Other CTCLs: Beyond MF/SS - T-Cell's Wild Cards

  • Lymphomatoid Papulosis (LyP): Chronic, recurrent, self-healing CD30+ papulonodules. Low systemic lymphoma risk (10-20%).
  • Primary Cutaneous Anaplastic Large Cell Lymphoma (pcALCL): Solitary/grouped CD30+ nodules/tumors. Generally good prognosis.
  • Subcutaneous Panniculitis-like T-cell Lymphoma (SPTCL): Deep nodules/plaques (panniculitis). α/β T-cell phenotype. Often associated with hemophagocytic syndrome.
  • Primary Cutaneous Gamma/Delta T-cell Lymphoma (PCGD-TCL): Aggressive. Ulceronecrotic plaques/tumors. Poor prognosis. Cutaneous T-cell Lymphoma and Lymphatic System

⭐ pcALCL typically presents with solitary or localized tumors and strong CD30 expression, carrying a favorable prognosis when confined to the skin (5-year survival >90%).

Cutaneous B-Cell Lymphomas: B-Cell Brigade - B-Team Defenders

  • Rarer than CTCLs; generally better prognosis. Usually CD20+.
  • Key Types:
    • PCMZL (Primary Cutaneous Marginal Zone): Indolent. Solitary/multiple nodules (trunk, arms). BCL2+, BCL6-.
    • PCFCL (Primary Cutaneous Follicle Center): Indolent. Papules/nodules (scalp, forehead, trunk). BCL6+, BCL2-.

      ⭐ PCFCL being BCL2-negative is a key distinction from systemic follicular lymphoma.

    • PCDLBCL, Leg Type (Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type): Aggressive. Tumors on one/both legs; elderly women. BCL2+, BCL6+, MUM1+.
  • Dx: Skin biopsy (histology, IHC). Rx: Local (radiotherapy, surgery), systemic (rituximab, chemo). Cutaneous B-Cell Lymphoma Subtypes: Topography, Cells, IHC

Diagnosis & Management: Unmask & Treat - Spot, Stage, Solve!

  • Spot (Diagnosis): Persistent, pruritic lesions. Crucial: Skin biopsy (histopathology, IHC, TCR gene rearrangement).
  • Stage (Staging): TNM classification. Blood for Sézary cells (MF/SS). Imaging (CT/PET) for advanced disease.
  • Solve (Management): Multidisciplinary. Skin-directed (topicals, phototherapy, RT) for early; Systemic (retinoids, IFN, chemo, targeted) for advanced.

    ⭐ Pautrier's microabscesses (intraepidermal collections of atypical lymphocytes) are characteristic of Mycosis Fungoides.

High‑Yield Points - ⚡ Biggest Takeaways

  • Mycosis Fungoides (MF): Most common CTCL, progresses patch → plaque → tumor. Pautrier's microabscesses are key.
  • Sézary Syndrome: Leukemic CTCL; erythroderma, lymphadenopathy, circulating Sézary cells (cerebriform nuclei).
  • Both MF & Sézary Syndrome are typically CD4+ T-cell lymphomas.
  • Lymphomatoid Papulosis (LyP): CD30+, recurrent, self-healing papules; low malignant risk.
  • Primary Cutaneous B-Cell Lymphomas (PCBCLs): Generally better prognosis than systemic counterparts.
  • Treatment: Topical therapies (steroids, PUVA) for early stages; systemic for advanced disease.

Practice Questions: Cutaneous Lymphomas

Test your understanding with these related questions

Mycosis fungoides primarily involves which type of immune cell?

1 of 5

Flashcards: Cutaneous Lymphomas

1/9

_____ syndrome is characterized by atypical CD4+ cells with cerebriform nuclei seen on blood smear

TAP TO REVEAL ANSWER

_____ syndrome is characterized by atypical CD4+ cells with cerebriform nuclei seen on blood smear

Sezary

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial